Evidence map›Paper›PMID 39711247›Full record

ArticleHistology and histopathology2025

Gradual expression of MMP9 and MT1-MMP at the tumor-stroma interface in head and neck squamous cell carcinoma.

Stefan Rusu, Vincent Nuyens, Alexandre Rousseau, Philippe Lothaire, Nathalie Nagy, Karim Zouaoui Boudjeltia, Pierrick Uzureau

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefan Rusu *Department of Pathology, Hôpital Universitaire de Bruxelles, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Vincent Nuyens *Laboratory of Experimental Medicine, Centre Hospitalier Universitaire de Charleroi-Chimay, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.
Alexandre RousseauLaboratory of Experimental Medicine, Centre Hospitalier Universitaire de Charleroi-Chimay, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.
Philippe LothaireDepartment of Surgery, Centre Hospitalier Universitaire de Charleroi-Chimay, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.
Nathalie NagyDepartment of Pathology, Centre Hospitalier Universitaire de Charleroi-Chimay, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.
Karim Zouaoui BoudjeltiaLaboratory of Experimental Medicine, Centre Hospitalier Universitaire de Charleroi-Chimay, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium.
Pierrick UzureauLaboratory of Experimental Medicine, Centre Hospitalier Universitaire de Charleroi-Chimay, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium. pierrick.uzureau@humani.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the late-stage diagnosis of head and neck squamous cell carcinoma (HNSCC), treatment remains a significant clinical challenge. The metalloproteinases MMP-9 and MT1-MMP play a pivotal role in extracellular matrix remodeling, thereby facilitating tumor growth and metastasis. Tumor progression requires the degradation of the basement membrane. The principal components of this structure, namely collagen IV and laminin, are the main targets of both MMP-9 and MT1-MMP. However, they can also exert influence over the expression of these enzymes. Oxidative stress plays an instrumental role in tumor development, functioning as a key inducer of metalloproteinase expression. The present study investigates the distribution of MMP-9 and MT1-MMP within tumor nests and along the basement membrane, comparing these with the distributions of collagen IV, laminin-332, and the antioxidant MnSOD. Biopsies from 12 patients with HNSCC and poor prognostic factors were subjected to immunofluorescence analysis. MMP-9 and MT1-MMP were found to be predominantly present in tumor cells, with a significant decrease in expression from the periphery to the center of tumor nests. Co-localization studies with laminin-332 and collagen IV, revealed substantial overlap, in accordance with the role of MMPs in basal membrane degradation. The cellular expression of laminin-332 associated with MMP-9 expression suggests an intricate relationship between metalloproteinases and their targets. While the previously observed pattern of glutathione-producing enzyme was similar to the metalloproteinases pattern, MnSOD expression was homogeneously distributed within tumor nests. Our findings reveal various distribution patterns of oxidative stress regulators, suggesting a complicated interplay in the development of HNSCC.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMatrix Metalloproteinase 14Matrix Metalloproteinase 9AgedBiomarkers, TumorCell Adhesion MoleculesCollagen Type IVFemaleHumansKalininMaleMiddle AgedSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorCell Adhesion MoleculesCollagen Type IVKalininMatrix Metalloproteinase 14Matrix Metalloproteinase 9MMP14 protein, humanMMP9 protein, human

Identifiers

PMID39711247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.